Among these potential targets, MAPK1, PIK3CA, EGFR, CCND1, and NFKBIA were identified as relatively high-degree targets, which played an essential role in cell proliferation and survival and were considered as the key markers of ZJP treatment on HCC. Here, CCND1 is linked to hepatocellular carcinoma.